Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-09-20

Clinical Trial Update: To Compare the Efficacy and Safety of LAYLA in Osteoarthritis Patients of the Knee [Phase 4]

View source ↗

Summary

Phase 4 trial update assessing efficacy and safety of LAYLA in osteoarthritis of the knee has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LAYLA

Snippet

Sponsor: PMG Pharm Co., Ltd | Conditions: Osteoarthritis of the Knee | Phase 4 | Status: COMPLETED